tiprankstipranks
Advertisement
Advertisement

HK:6628 Stock Latest News

Transcenta Revamps Chinese Stock Short Name and Corporate Logo to Sharpen Biopharma Focus
Company AnnouncementsTranscenta Revamps Chinese Stock Short Name and Corporate Logo to Sharpen Biopharma Focus
58m ago
6628
Transcenta Narrows Annual Loss on Cost Cuts Despite Revenue Decline
PremiumCompany Announcements
Transcenta Narrows Annual Loss on Cost Cuts Despite Revenue Decline
8d ago
6628
Transcenta Sets Board Meeting to Approve 2025 Annual Results and Consider Final Dividend
PremiumCompany Announcements
Transcenta Sets Board Meeting to Approve 2025 Annual Results and Consider Final Dividend
21d ago
6628
Transcenta Tightens Costs and Bolsters Liquidity Ahead of Oppenheimer Conference
PremiumCompany Announcements
Transcenta Tightens Costs and Bolsters Liquidity Ahead of Oppenheimer Conference
1M ago
6628
Transcenta Advances Dealmaking, Licensing and Financing to Resolve Audit Disclaimer and Bolster Liquidity
PremiumCompany Announcements
Transcenta Advances Dealmaking, Licensing and Financing to Resolve Audit Disclaimer and Bolster Liquidity
3M ago
6628
Transcenta Grants 2 Million Incentive Shares to Key Employee Under Performance-Linked Scheme
PremiumCompany AnnouncementsTranscenta Grants 2 Million Incentive Shares to Key Employee Under Performance-Linked Scheme
3M ago
6628
Transcenta Licenses HiCB Biomanufacturing Platform to EirGenix in Strategic Collaboration
Premium
Company Announcements
Transcenta Licenses HiCB Biomanufacturing Platform to EirGenix in Strategic Collaboration
3M ago
6628
Transcenta’s Osemitamab Shows Promising Results in Cancer Trial
Premium
Company Announcements
Transcenta’s Osemitamab Shows Promising Results in Cancer Trial
4M ago
6628
Transcenta Announces Share and Option Grants to Boost Strategic Goals
PremiumCompany Announcements
Transcenta Announces Share and Option Grants to Boost Strategic Goals
5M ago
6628
Transcenta Holding Limited Announces Auditor Change to Ernst & Young
PremiumCompany Announcements
Transcenta Holding Limited Announces Auditor Change to Ernst & Young
5M ago
6628
Transcenta’s Partner Inhibrx Reports Positive Phase 2 Results for Ozekibart in Chondrosarcoma
PremiumCompany Announcements
Transcenta’s Partner Inhibrx Reports Positive Phase 2 Results for Ozekibart in Chondrosarcoma
5M ago
6628
Transcenta Advances Financial and Strategic Initiatives to Strengthen Position
PremiumCompany Announcements
Transcenta Advances Financial and Strategic Initiatives to Strengthen Position
6M ago
6628
Transcenta Explores Blockchain-Based Financing for Oncology Innovations
PremiumCompany AnnouncementsTranscenta Explores Blockchain-Based Financing for Oncology Innovations
7M ago
6628
Transcenta Completes HK$59.34 Million Share Placement
Premium
Company Announcements
Transcenta Completes HK$59.34 Million Share Placement
7M ago
6628
Transcenta Holding Limited Announces New Share Placement to Raise HK$59.34 Million
Premium
Company Announcements
Transcenta Holding Limited Announces New Share Placement to Raise HK$59.34 Million
7M ago
6628
Transcenta Reports Interim Results with Strategic Adjustments
PremiumCompany Announcements
Transcenta Reports Interim Results with Strategic Adjustments
7M ago
6628
Transcenta Holding Limited Schedules Board Meeting to Review Interim Results
PremiumCompany Announcements
Transcenta Holding Limited Schedules Board Meeting to Review Interim Results
8M ago
6628
Transcenta Implements Strategic Measures to Enhance Financial Stability and Pipeline Development
PremiumCompany Announcements
Transcenta Implements Strategic Measures to Enhance Financial Stability and Pipeline Development
9M ago
6628
Transcenta Clarifies Option Grant to Consultant Dr. Caroline Germa
PremiumCompany Announcements
Transcenta Clarifies Option Grant to Consultant Dr. Caroline Germa
9M ago
6628
Transcenta Grants Shares and Options to Key Employees
PremiumCompany AnnouncementsTranscenta Grants Shares and Options to Key Employees
10M ago
6628
Transcenta Holding Limited Announces Successful AGM Outcomes
Premium
Company Announcements
Transcenta Holding Limited Announces Successful AGM Outcomes
10M ago
6628
Transcenta Unveils Promising Osemitamab Trial Results at ASCO 2025
Premium
Company Announcements
Transcenta Unveils Promising Osemitamab Trial Results at ASCO 2025
10M ago
6628

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >